Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Breathox for acute COVID-19 symptoms
NCT05196581Phase 2Completed
- Start
- Dec 2021
- Primary completion
- Jul 2022
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of sodium chloride in coronavirus disease 2019 (COVID-19). Started Dec 2021; status: completed.
02
Drugs
sodium chloride
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05196581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05196581.